Skip to content

MusclePharm Corporation

CIK 0001415684

← back to feed
Revenue (TTM)
$53.1M
−22.3% YoY Q1 May 2022
Net Income (TTM)
−$12.39M
−504.0% YoY Q1 May 2022
EPS Diluted (TTM)
−$0.30
−657.1% YoY Q1 May 2022
Gross Margin
13.9%
Q1 May 2022
Operating Margin
-13.9%
Q1 May 2022
Net Margin
-23.3%
Q1 May 2022
Free Cash Flow (TTM)
−$8.18M
Q1 May 2022
Cash
$534K
Q1 May 2022
Total Debt
$1.08M
Q1 May 2022
Shares Outstanding
34.35M sh
Q1 May 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings